Reversal by the selective D-2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensives

C. Lombardi, R. De Cotiis, C. Spedini, C. Missale, M. Memo, P. F. Spano

Research output: Contribution to journalArticle

Abstract

The aim of the study was to define the role of peripheral dopaminergic mechanisms in the regulation of blood pressure. The data suggest that the hypotensive effect of the dopaminergic agonist co-dergocrine in elderly hypertensive patients is mediated by interaction with peripheral DA-2 receptors, since it was reversed by the selective antagonist sulpiride in a dose that does not significantly cross the blood brain barrier. The findings suggest the possible therapeutic use of dopamine DA-2 agonists in elderly hypertensive patients.

Original languageEnglish
Pages (from-to)519-521
Number of pages3
JournalEuropean Journal of Clinical Pharmacology
Volume33
Issue number5
DOIs
Publication statusPublished - Sep 1987

Keywords

  • co-dergocrine
  • DA-2 receptors
  • dopamine
  • hypertension
  • sulpiride

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Reversal by the selective D-2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensives'. Together they form a unique fingerprint.

  • Cite this